Menu
Back to Journals » Vascular Health and Risk Management » Volume 16
Review
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,958 | Dovepress* | 8,304+ | 1,825 | 10,129 | |
| PubMed Central* | 3,654 | 731 | 4,385 | ||
| Totals | 11,958 | 2,556 | 14,514 | ||
| *Since 16 January 2020 | |||||
View citations on PubMed Central and Google Scholar